rheumatology
Rare diseases

Glucocorticoid use a risk factor for more severe outcomes in COVID-19

People with rheumatic disease who develop COVID-19 may be at risk of more severe disease, especially if they are on moderate- to high-dose glucocorticoids, a new study suggests. However, the review of COVID-19 outcomes for patients with immune-mediated inflammatory disease (IMID) found that they are otherwise not at higher risk of developing COVID-19 and most ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic